|
AstraZeneca Pharma India Ltd.
|
Balance Sheet
|
|
|
You can view the
Balance Sheet
for the last 5 years.
|
Market Cap. (Rs.)
|
21357.50 Cr.
|
P/BV
|
25.68
|
Book Value (Rs.)
|
332.64
|
|
52 Week High/Low (Rs.)
|
10691/6730
|
FV/ML
|
2/1
|
P/E(X)
|
184.53
|
|
Bookclosure
|
18/07/2025
|
EPS (Rs.)
|
46.30
|
Div Yield (%)
|
0.37
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| No. of Equity Shares (in Lacs) | 250.00 | 250.00 | 250.00 | 250.00 | 250.00 |
| | | | | | |
| EQUITIES AND LIABILITIES | | | | | |
| SHAREHOLDER'S FUNDS | | | | | |
| Equity Share Capital | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Total Share Capital | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| | | | | | |
| Reserves and Surplus | 765.35 | 706.92 | 583.69 | 506.39 | 451.17 |
| Total Reserves and Surplus | 765.35 | 706.92 | 583.69 | 506.39 | 451.17 |
| Total Shareholders Funds | 770.35 | 711.92 | 588.69 | 511.39 | 456.17 |
| | | | | | |
| NON-CURRENT LIABILITIES | | | | | |
| Other Long Term Liabilities | 38.45 | 2.78 | 3.69 | 5.02 | 8.63 |
| Long Term Provisions | 6.32 | 6.21 | 8.56 | 7.50 | 6.41 |
| Total Non-Current Liabilities | 44.77 | 8.99 | 12.25 | 12.52 | 15.04 |
| | | | | | |
| CURRENT LIABILITIES | | | | | |
| Trade Payables | 456.30 | 196.51 | 227.88 | 188.06 | 178.37 |
| Other Current Liabilities | 140.17 | 117.19 | 114.37 | 104.42 | 88.21 |
| Short Term Provisions | 106.53 | 43.42 | 41.68 | 40.17 | 36.92 |
| Total Current Liabilities | 703.00 | 357.12 | 383.93 | 332.65 | 303.50 |
| | | | | | |
| Total Capital And Liabilities | 1518.12 | 1078.03 | 984.87 | 856.56 | 774.71 |
| | | | | | |
| ASSETS | | | | | |
| NON-CURRENT ASSETS | | | | | |
| Tangible Assets | 63.58 | 64.57 | 68.86 | 74.49 | 80.96 |
| Intangible Assets | 0.66 | 2.11 | 0.00 | 0.00 | 0.00 |
| Capital Work-In-Progress | 0.00 | 0.27 | 1.33 | 2.20 | 4.02 |
| Fixed Assets | 64.24 | 66.95 | 70.19 | 76.69 | 84.98 |
| Deferred Tax Assets [Net] | 41.56 | 21.25 | 20.67 | 16.30 | 14.53 |
| Long Term Loans And Advances | 0.11 | 0.27 | 0.88 | 0.41 | 4.33 |
| Other Non-Current Assets | 69.86 | 56.85 | 57.66 | 57.49 | 52.11 |
| Total Non-Current Assets | 175.77 | 145.32 | 149.40 | 150.89 | 155.95 |
| | | | | | |
| | | | | | |
| CURRENT ASSETS | | | | | |
| Inventories | 548.50 | 227.88 | 190.21 | 140.22 | 159.80 |
| Trade Receivables | 184.88 | 153.13 | 107.52 | 85.89 | 85.19 |
| Cash And Cash Equivalents | 536.70 | 505.84 | 500.48 | 448.46 | 352.35 |
| Short Term Loans And Advances | 0.30 | 0.13 | 0.08 | 0.09 | 0.36 |
| OtherCurrentAssets | 71.97 | 45.73 | 37.18 | 31.01 | 21.06 |
| Total Current Assets | 1342.35 | 932.71 | 835.47 | 705.67 | 618.76 |
| | | | | | |
| Total Assets | 1518.12 | 1078.03 | 984.87 | 856.56 | 774.71 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
| Contingent Liabilities | 98.51 | 138.25 | 132.28 | 124.60 | 89.17 |
| | | | | | |
| BONUS DETAILS | | | | | |
| Bonus Equity Share Capital | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 |
